Showing results (1641-1650 of 1,694) with videos related to
Sort By:
Pageof 170
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 23, 2023
Field Synopsis of Environmental and Genetic Risk Factors of Sporadic Early-Onset Colorectal Cancer and Advanced AdenomaRongqi Zhang, Daniel Boakye, Nan Yang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2018
STAT3/HOTAIR Signaling Axis Regulates HNSCC Growth in an EZH2-dependent MannerShanshan Sun, Yansheng Wu, Wenyu Guo, et al.Proceedings of the National Academy of Sciences of the United States of America|January 30, 2014
Discrete mechanisms of mTOR and cell cycle regulation by AMPK agonists independent of AMPKXiaona Liu, Rishi Raj Chhipa, Shabnam Pooya, et al.The American Journal of Gastroenterology|January 25, 2023
The Contribution of Genetic Risk and Lifestyle Factors in the Development of Adult-Onset Inflammatory Bowel Disease: A Prospective Cohort StudyYuhao Sun, Shuai Yuan, Xuejie Chen, et al.European Heart Journal. Cardiovascular Pharmacotherapy|March 30, 2022
Platelet P2Y12 inhibiting therapy in adjunct to vascular dose of rivaroxaban or aspirin: a pharmacodynamic study of dual pathway inhibition vs. dual antiplatelet therapyMattia Galli, Francesco Franchi, Fabiana Rollini, et al.Journal of Hematology & Oncology|April 20, 2016
Correlation between deletion of the CDKN2 gene and tyrosine kinase inhibitor resistance in adult Philadelphia chromosome-positive acute lymphoblastic leukemiaNa Xu, Yu-ling Li, Xuan Li, et al.Journal of Primary Care & Community Health|October 5, 2025
Effects of Tuina in Patients With Chronic Nonspecific Low Back Pain: A Randomized Controlled TrialJuan Yang, Alexander Do, Jennifer N Soderlind, et al.The Lancet. Oncology|March 7, 2021
Pembrolizumab versus investigator-choice chemotherapy for metastatic triple-negative breast cancer (KEYNOTE-119): a randomised, open-label, phase 3 trialEric P Winer, Oleg Lipatov, Seock-Ah Im, et al.Zhongguo Shi Yan Xue Ye Xue Za Zhi|April 26, 2014
[Comparison of the efficacy of two chemotherapy protocols for children with TEL-AML1[STBZ] fusion gene positive acute lymphoblastic leukemia]Kai-Ling Wang, Yan-Yan Mei, Lei Cui, et al.The New England Journal of Medicine|July 20, 2022
Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast CancerJavier Cortes, Hope S Rugo, David W Cescon, et al.Pageof 170